Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and its Expression Associates with Favorable Survival for Stage III Melanoma

PURPOSE: Inflammatory marker expression in stage III melanoma tumors was evaluated for association with outcome, using two independent cohorts of stage III melanoma patients’ tumor tissues. EXPERIMENTAL DESIGN: Fifteen markers of interest were selected for analysis, and their expression in melanoma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Ekmekcioglu, Suhendan, Davies, Michael A., Tanese, Keiji, Roszik, Jason, Shin-Sim, Myung, Bassett, Roland L., Milton, Denái R., Woodman, Scott E., Prieto, Victor G., Gershenwald, Jeffrey E., Morton, Donald L., Hoon, Dave S., Grimm, Elizabeth A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911309/
https://ncbi.nlm.nih.gov/pubmed/26783288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2226
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items